{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:34:45Z","timestamp":1776123285052,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2014,3,2]],"date-time":"2014-03-02T00:00:00Z","timestamp":1393718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Osteogenic factors are often used in orthopedics to promote bone growth, improve fracture healing, and induce spine fusion. Osteogenic oxysterols are naturally occurring molecules that were shown to induce osteogenic differentiation in vitro and promote spine fusion in vivo. The purpose of this study was to identify an osteogenic oxysterol more suitable for clinical development than those previously reported, and evaluate its ability to promote osteogenesis in vitro and spine fusion in rats in vivo. Among more than 100 oxysterol analogues synthesized, Oxy133 induced significant expression of osteogenic markers Runx2, osterix (OSX), alkaline phosphatase (ALP), bone sialoprotein (BSP), and osteocalcin (OCN) in C3H10T1\/2 mouse embryonic fibroblasts and in M2-10B4 mouse marrow stromal cells. Oxy133-induced activation of an 8X-Gli luciferase reporter, its direct binding to Smoothened, and the inhibition of Oxy133-induced osteogenic effects by the Hedgehog (Hh) pathway inhibitor, cyclopamine, demonstrated the role of Hh pathway in mediating osteogenic responses to Oxy133. Oxy133 did not stimulate osteogenesis via BMP or Wnt signaling. Oxy133 induced the expression of OSX, BSP, and OCN, and stimulated robust mineralization in primary human mesenchymal stem cells. In vivo, bilateral spine fusion occurred through endochondral ossification and was observed in animals treated with Oxy133 at the fusion site on X-ray after 4 weeks and confirmed with manual assessment, micro-CT (\u00b5CT), and histology after 8 weeks, with equal efficiency to recombinant human bone morphogenetic protein-2 (rhBMP-2). Unlike rhBMP-2, Oxy133 did not induce adipogenesis in the fusion mass and resulted in denser bone evidenced by greater bone volume\/tissue volume (BV\/TV) ratio and smaller trabecular separation. Findings here suggest that Oxy133 has significant potential as an osteogenic molecule with greater ease of synthesis and improved time to fusion compared to previously studied oxysterols. Small molecule osteogenic oxysterols may serve as the next generation of bone anabolic agents for therapeutic development. \u00a9 2014 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2213","type":"journal-article","created":{"date-parts":[[2014,3,3]],"date-time":"2014-03-03T09:37:50Z","timestamp":1393839470000},"page":"1872-1885","source":"Crossref","is-referenced-by-count":56,"title":["A Novel Osteogenic Oxysterol Compound for Therapeutic Development to Promote Bone Growth: Activation of Hedgehog Signaling and Osteogenesis Through Smoothened Binding"],"prefix":"10.1093","volume":"29","author":[{"given":"Scott R","family":"Montgomery","sequence":"first","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taya","family":"Nargizyan","sequence":"additional","affiliation":[{"name":"Department of MedicineDavid Geffen School of Medicine, UCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Meliton","sequence":"additional","affiliation":[{"name":"Department of MedicineDavid Geffen School of Medicine, UCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Nachtergaele","sequence":"additional","affiliation":[{"name":"Department of BiochemistryStanford University School of MedicineStanfordCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Rohatgi","sequence":"additional","affiliation":[{"name":"Department of MedicineStanford University School of MedicineStanfordCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Stappenbeck","sequence":"additional","affiliation":[{"name":"Department of MedicineDavid Geffen School of Medicine, UCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Chemistry and BiochemistryUCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared S","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayan","family":"Aghdasi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Weintraub","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Atti","sequence":"additional","affiliation":[{"name":"School of DentistryUCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios","family":"Tetradis","sequence":"additional","affiliation":[{"name":"School of DentistryUCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata C","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Pediatric NephrologyUCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akishige","family":"Hokugo","sequence":"additional","affiliation":[{"name":"Department of Plastic SurgeryUCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raed","family":"Alobaidaan","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of California, Los Angeles (UCLA)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodor J","family":"Hahn","sequence":"additional","affiliation":[{"name":"Veterans' Administration (VA) Greater Los Angeles Healthcare System and Geriatric Research, Education, and Clinical CenterLos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey C","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Orthopedic SurgeryUniversity of Southern California (USC)Los AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Parhami","sequence":"additional","affiliation":[{"name":"Department of MedicineDavid Geffen School of Medicine, UCLALos AngelesCAUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,3,2]]},"reference":[{"key":"2024020318495815200_jbmr2213-bib-0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00003086-200002000-00008","article-title":"Human bone morphogenetic protein allografting for reconstruction of femoral nonunion","volume":"371","author":"Johnson","year":"2000","journal-title":"Clin Orthop Relat Res"},{"key":"2024020318495815200_jbmr2213-bib-0002","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.med.53.082901.104047","article-title":"Directions of drug discovery in osteoporosis","volume":"53","author":"Mundy","year":"2002","journal-title":"Annu Rev Med"},{"key":"2024020318495815200_jbmr2213-bib-0003","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"2024020318495815200_jbmr2213-bib-0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00003086-200202000-00005","article-title":"Osteoinductive molecules in orthopaedics: basic science and preclinical studies","volume":"395","author":"Yoon","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"2024020318495815200_jbmr2213-bib-0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00003086-199608000-00037","article-title":"Complications of iliac crest bone graft harvesting","volume":"329","author":"Arrington","year":"1996","journal-title":"Clin Orthop Relat Res"},{"key":"2024020318495815200_jbmr2213-bib-0006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1529-9430(02)00180-8","article-title":"Bone grafting alternatives in spinal surgery","volume":"2","author":"Vaccaro","year":"2002","journal-title":"Spine J"},{"key":"2024020318495815200_jbmr2213-bib-0007","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/BRS.0b013e3181d25803","article-title":"Graft options in posterolateral and posterior interbody lumbar fusion","volume":"35","author":"Rihn","year":"2010","journal-title":"Spine"},{"key":"2024020318495815200_jbmr2213-bib-0008","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1001\/jama.2011.1371","article-title":"Questions about spine fusion product prompt a new process for reviewing data","volume":"306","author":"Mitka","year":"2011","journal-title":"JAMA"},{"key":"2024020318495815200_jbmr2213-bib-0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.spinee.2007.01.011","article-title":"Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases","volume":"7","author":"Lewandrowski","year":"2007","journal-title":"Spine J"},{"key":"2024020318495815200_jbmr2213-bib-0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.spinee.2007.06.014","article-title":"Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF\/TLIF use of bone morphogenetic protein-2 (BMP-2)","volume":"8","author":"Wong","year":"2008","journal-title":"Spine J"},{"key":"2024020318495815200_jbmr2213-bib-0011","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.brs.0000245863.52371.c2","article-title":"Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine","volume":"31","author":"Smucker","year":"2006","journal-title":"Spine"},{"key":"2024020318495815200_jbmr2213-bib-0012","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.spinee.2011.04.023","article-title":"A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned","volume":"11","author":"Carragee","year":"2011","journal-title":"Spine J"},{"key":"2024020318495815200_jbmr2213-bib-0013","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1359\/jbmr.040115","article-title":"Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat","volume":"19","author":"Kha","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024020318495815200_jbmr2213-bib-0014","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1359\/jbmr.070710","article-title":"20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a Hedgehog-dependent mechanism","volume":"22","author":"Kim","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2024020318495815200_jbmr2213-bib-0015","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/jcb.23082","article-title":"Novel oxysterols have pro-osteogenic and anti-adipogenic effects in vitro and induce spinal fusion in vivo","volume":"112","author":"Johnson","year":"2011","journal-title":"J Cell Biochem"},{"key":"2024020318495815200_jbmr2213-bib-0016","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00223-008-9189-3","article-title":"Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1\/2","volume":"84","author":"Zhao","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"2024020318495815200_jbmr2213-bib-0017","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/01.ATV.17.4.680","article-title":"Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients","volume":"17","author":"Parhami","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024020318495815200_jbmr2213-bib-0018","doi-asserted-by":"crossref","first-page":"8959","DOI":"10.1074\/jbc.M611741200","article-title":"Oxysterols are novel activators of the Hedgehog signaling pathway in pluripotent mesenchymal cells","volume":"282","author":"Dwyer","year":"2007","journal-title":"J Biol Chem"},{"key":"2024020318495815200_jbmr2213-bib-0019","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/jcb.22846","article-title":"Hedgehog signaling and osteogenic differentiation in multipotent bone marrow stromal cells are inhibited by oxidative stress","volume":"111","author":"Kim","year":"2010","journal-title":"J Cell Biochem"},{"key":"2024020318495815200_jbmr2213-bib-0020","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nchembio.765","article-title":"Oxysterols are allosteric activators of the oncoprotein Smoothened","volume":"8","author":"Nachtergaele","year":"2012","journal-title":"Nat Chem Biol"},{"key":"2024020318495815200_jbmr2213-bib-0021","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1073\/pnas.0813373106","article-title":"Hedgehog signal transduction by Smoothened: pharmacologic evidence for a 2-step activation process","volume":"106","author":"Rohatgi","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024020318495815200_jbmr2213-bib-0022","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/BRS.0b013e31817e9dfd","article-title":"The adjunctive effect of a binding peptide on bone morphogenetic protein enhanced bone healing in a rodent model of spinal fusion","volume":"33","author":"Alanay","year":"2008","journal-title":"Spine"},{"key":"2024020318495815200_jbmr2213-bib-0023","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/BSD.0b013e31814cf51d","article-title":"The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats","volume":"21","author":"Miyazaki","year":"2008","journal-title":"J Spinal Disord Tech"},{"key":"2024020318495815200_jbmr2213-bib-0024","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bone.2006.09.028","article-title":"CCAAT\/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia","volume":"40","author":"Pereira","year":"2007","journal-title":"Bone"},{"key":"2024020318495815200_jbmr2213-bib-0025","first-page":"373","article-title":"Ostene, a new alkylene oxide copolymer bone hemostatic material, does not inhibit bone healing","volume":"63","author":"Magyar","year":"2008","journal-title":"Neurosurgery"},{"issue":"9","key":"2024020318495815200_jbmr2213-bib-0026","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nchembio.1290","article-title":"Oxysterol binding to the extracellular domain of Smoothened in Hedgehog signaling","volume":"9","author":"Nedelcu","year":"2013","journal-title":"Nat Chem Biol"},{"key":"2024020318495815200_jbmr2213-bib-0027","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jcb.21112","article-title":"Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway","volume":"100","author":"Richardson","year":"2007","journal-title":"J Cell Biochem"},{"key":"2024020318495815200_jbmr2213-bib-0028","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jcb.21840","article-title":"Oxysterol-induced osteogenic differentiation of marrow stromal cells is regulated by Dkk-1 inhibitable and PI3-kinase mediated signaling","volume":"105","author":"Amantea","year":"2008","journal-title":"J Cell Biochem"},{"key":"2024020318495815200_jbmr2213-bib-0029","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.2106\/JBJS.J.00081","article-title":"Full-length spp24, but not its 18.5-kDa proteolytic fragment, inhibits bone-healing in a rodent model of spine fusion","volume":"93","author":"Sintuu","year":"2011","journal-title":"J Bone Joint Surg Am"},{"key":"2024020318495815200_jbmr2213-bib-0030","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.spinee.2008.08.009","article-title":"A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats","volume":"9","author":"Miyazaki","year":"2009","journal-title":"Spine J"},{"key":"2024020318495815200_jbmr2213-bib-0031","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1359\/jbmr.040821","article-title":"Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model","volume":"19","author":"Zhu","year":"2004","journal-title":"J Bone Miner Res"},{"key":"2024020318495815200_jbmr2213-bib-0032","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.brs.0000201424.27509.72","article-title":"Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion","volume":"31","author":"Shields","year":"2006","journal-title":"Spine"},{"key":"2024020318495815200_jbmr2213-bib-0033","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.BRS.0000065486.22141.CA","article-title":"A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate","volume":"28","author":"Baskin","year":"2003","journal-title":"Spine"},{"key":"2024020318495815200_jbmr2213-bib-0034","doi-asserted-by":"crossref","first-page":"E1350","DOI":"10.1097\/BRS.0b013e3181e85756","article-title":"Cytokine-mediated inflammatory reaction following posterior cervical decompression and fusion associated with recombinant human bone morphogenetic protein-2: a case study","volume":"35","author":"Robin","year":"2010","journal-title":"Spine"},{"key":"2024020318495815200_jbmr2213-bib-0035","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1227\/01.NEU.0000369517.21018.F2","article-title":"Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions","volume":"66","author":"Garrett","year":"2010","journal-title":"Neurosurgery"},{"key":"2024020318495815200_jbmr2213-bib-0036","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3171\/2010.9.SPINE09828","article-title":"Analysis of prevertebral soft-tissue swelling and dysphagia in multilevel anterior cervical discectomy and fusion with recombinant human bone morphogenetic protein-2 in patients at risk for pseudarthrosis","volume":"14","author":"Stachniak","year":"2011","journal-title":"J Neurosurg Spine"},{"key":"2024020318495815200_jbmr2213-bib-0037","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/ten.tea.2010.0555","article-title":"High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo","volume":"17","author":"Zara","year":"2011","journal-title":"Tissue Eng Part A"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2213","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/8\/1872\/56564996\/jbmr2213.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/29\/8\/1872\/56564996\/jbmr2213.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:51:48Z","timestamp":1710341508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/29\/8\/1872-1885\/7598841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,2]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,3,2]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2213","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,8,1]]},"published":{"date-parts":[[2014,3,2]]}}}